HK66193A - Method for production of stable nicorandil preparation - Google Patents

Method for production of stable nicorandil preparation Download PDF

Info

Publication number
HK66193A
HK66193A HK661/93A HK66193A HK66193A HK 66193 A HK66193 A HK 66193A HK 661/93 A HK661/93 A HK 661/93A HK 66193 A HK66193 A HK 66193A HK 66193 A HK66193 A HK 66193A
Authority
HK
Hong Kong
Prior art keywords
acid
nicorandil
saturated higher
tablets
preparation
Prior art date
Application number
HK661/93A
Other languages
German (de)
English (en)
French (fr)
Inventor
Yoshimitsu Iida
Shuji Sumida
Original Assignee
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26342067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK66193(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Seiyaku Kabushiki Kaisha filed Critical Chugai Seiyaku Kabushiki Kaisha
Publication of HK66193A publication Critical patent/HK66193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK661/93A 1986-01-17 1993-07-08 Method for production of stable nicorandil preparation HK66193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP772286 1986-01-17
JP6185686 1986-03-19

Publications (1)

Publication Number Publication Date
HK66193A true HK66193A (en) 1993-07-16

Family

ID=26342067

Family Applications (1)

Application Number Title Priority Date Filing Date
HK661/93A HK66193A (en) 1986-01-17 1993-07-08 Method for production of stable nicorandil preparation

Country Status (21)

Country Link
US (1) US4822808A (cs)
EP (1) EP0230932B1 (cs)
KR (1) KR940000232B1 (cs)
CN (1) CN1009525B (cs)
AR (1) AR241514A1 (cs)
AU (1) AU591958B2 (cs)
CA (1) CA1285486C (cs)
CS (1) CS276587B6 (cs)
DE (1) DE3769662D1 (cs)
DK (1) DK174918B1 (cs)
EG (1) EG18088A (cs)
ES (1) ES2054623T3 (cs)
FI (1) FI87043C (cs)
GR (1) GR3002288T3 (cs)
HK (1) HK66193A (cs)
HU (1) HU196705B (cs)
MX (1) MX167912B (cs)
NO (1) NO173590C (cs)
NZ (1) NZ218917A (cs)
PT (1) PT84124B (cs)
SG (1) SG64893G (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637322A (en) * 1992-11-06 1997-06-10 Japan Tobacco Inc. Method for producing composition for solid medicine
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
ATE308342T1 (de) * 1997-08-08 2005-11-15 Chugai Pharmaceutical Co Ltd Arzneimittel gegen diabetes-komplikationen
AU748359B2 (en) * 1998-05-15 2002-06-06 Chugai Seiyaku Kabushiki Kaisha Controlled-release formulations
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
FR2872705B1 (fr) * 2004-07-08 2008-07-18 Aventis Pharma Sa Compositions contenant du nicorandil, procede de preparation et utilisation
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
SI2098249T1 (sl) * 2008-03-05 2013-02-28 Rivopharm Sa Nosilci nikorandila s povečano stabilnostjo
KR20100007082A (ko) * 2008-07-11 2010-01-22 주식회사 엘지생명과학 니코란딜을 포함하는 서방성 제제
CN102186474A (zh) * 2008-08-14 2011-09-14 杏林制药株式会社 稳定的医药组合物
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法
CN111574441B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 一种尼可地尔与水杨酸的共晶及其制备方法和应用
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法
CN115317456A (zh) * 2022-08-17 2022-11-11 北京科源创欣科技有限公司 一种尼可地尔片组合物及其制备方法
CN115282123B (zh) * 2022-09-13 2023-11-03 南京比逊医药科技有限公司 一种稳定的尼可地尔制剂的制备方法
CN117547534B (zh) * 2023-11-10 2024-07-12 江南大学 尼可地尔缓释制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent

Also Published As

Publication number Publication date
HUT44435A (en) 1988-03-28
FI87043C (fi) 1992-11-25
CA1285486C (en) 1991-07-02
FI87043B (fi) 1992-08-14
CN87100285A (zh) 1987-08-19
AR241514A1 (es) 1992-08-31
NO173590C (no) 1994-01-05
AU6764887A (en) 1987-07-23
EG18088A (en) 1992-08-30
FI870131L (fi) 1987-07-18
PT84124A (en) 1987-02-01
DK19187A (da) 1987-07-18
ES2054623T3 (es) 1994-08-16
SG64893G (en) 1993-08-06
EP0230932A3 (en) 1987-12-09
PT84124B (pt) 1989-02-28
DK174918B1 (da) 2004-02-23
EP0230932A2 (en) 1987-08-05
KR940000232B1 (ko) 1994-01-12
EP0230932B1 (en) 1991-05-02
US4822808A (en) 1989-04-18
CS8700282A2 (en) 1991-07-16
NO870212D0 (no) 1987-01-19
KR870006894A (ko) 1987-08-13
DE3769662D1 (de) 1991-06-06
HU196705B (en) 1989-01-30
DK19187D0 (da) 1987-01-15
MX167912B (es) 1993-04-22
NO870212L (no) 1987-07-20
GR3002288T3 (en) 1992-12-30
FI870131A0 (fi) 1987-01-14
CS276587B6 (en) 1992-07-15
NZ218917A (en) 1989-10-27
NO173590B (no) 1993-09-27
CN1009525B (zh) 1990-09-12
AU591958B2 (en) 1989-12-21

Similar Documents

Publication Publication Date Title
EP0230932B1 (en) Method for production of stable nicorandil preparation
US4803213A (en) Method for production of stable nicorandil preparation
US4343789A (en) Sustained release pharmaceutical composition of solid medical material
EP0519099A1 (en) Direct compression cyclophosphamide tablet
EP0219161B1 (en) Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
NL8500724A (nl) Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
US3362880A (en) Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US4781925A (en) Calcium supplement compressed tablets
JP2532224B2 (ja) ニコランジル錠剤の製法
JP2512302B2 (ja) ニコランジル安定化製剤の製造方法
FI96480B (fi) Menetelmä pitkävaikutteisen moniraetabletin valmistamiseksi
EP2108365A1 (en) Single dosage pharmaceutical formulation comprising eprosartan mesylate
EP1322294B1 (en) Stabilization of solid thyroid drug formulations
AU681980B2 (en) Preparation of fusidic acid tablets
JPH0769889A (ja) ニコランジル錠剤の製法
EP2585051B1 (en) Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
JPH0215522B2 (cs)
CN115317456A (zh) 一种尼可地尔片组合物及其制备方法
EP1872777A1 (en) Pharmaceutical composition comprising tetrahydrolipstatin
NO841437L (no) Fremgangsmaate for fremstilling av orale doseringsformer av medisinsk aktive 1,4-dihydropyridin-derivater

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20070115